Guarnaschelli MF, Marrodan M, Sosa BE, Perez Arana CI, et al. Early use of high-efficacy disease-modifying therapies reduces the risk of progression independent of relapse and MRI activity in patients with relapsing-remitting multiple sclerosis. Mult Scler 2026 Apr 29:13524585261442036. doi: 10.1177/13524585261442036.
PMID: 42057337